Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Dick W who wrote (2902)	7/28/1999 6:00:00 PM
From: Sylvester	Respond to of 4140

Jesse Eisinger: In response to your article Defiant Spirit Doesn't Set on Sunrise, the doctors who did the procedure have patients who are very pleased with the surgery. There is a small percentage of patients who regressed, but the numbers were not statistically significant. So why did this happen and how will it be corrected? I think the FDA is not happy with so many investigators being investors. From a scientific approach, I don't blame them. When did science leave medicine and become strictly a business? If ophthalmology cannot control the need for investigators to make millions, then the FDA has a responsibility to patients to do it for them. It is about time that the research is sent back to be done by investigators that have no financial benefit or loss from the testing. The FDA panel should come out and say this directly instead of making no sense in denying approval for reasons that are not medically sound. The panel deserves to be taken to task for their actions. The members should be made known to the public and made to answer for their actions. This is still an open system of government, and an action that affects the people should not be made by people who do not have to be held accountable. -- Ira Garoon (received 7/27)